Search

everythinglearnresearchcommunity

for

Search:↓

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

Normal BMI is linked to higher rates of androgenetic alopecia.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

PRP injections improve hair thickness for baldness.

Double-spin PRP is more effective for treating male pattern baldness.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Intralesional vitamin D is mildly effective for treating Alopecia Areata.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Iron and ferritin levels don't affect alopecia areata.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Ice packs and vibration devices can reduce pain during scalp injections.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Vitamin D levels are not linked to alopecia areata.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

The document's conclusion cannot be determined from the provided text.

The protocol is easy to use, but reliable results need the same person to assess each time.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.